Nordson increased its revenue from $1.7 billion in FY 2015 to $2.7 billion in FY 2024, a compound annual growth rate of 5.3%.

Outlook Therapeutics Stock (NASDAQ: OTLK) stock price, news, charts, stock research, profile.

We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.